CytoDyn Inc. Common Stock Shares Outstanding

• CytoDyn Inc. showed an increase of +18.0% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2011: 22.29 million shares | Q1 2012: 28.11 million shares | Q4 2012: 29.91 million shares | Q1 2013: 30.75 million shares | Q3 2013: 32.04 million shares | Q4 2013: 55.34 million shares | Q1 2014: 55.57 million shares | Q3 2014: 55.75 million shares | Q4 2014: 58.73 million shares | Q1 2015: 59.26 million shares | Q3 2015: 63.64 million shares | Q4 2015: 63.64 million shares | Q1 2016: 63.64 million shares | Q3 2016: 123.34 million shares | Q4 2016: 138.22 million shares | Q1 2017: 149.47 million shares | Q3 2017: 152.76 million shares | Q4 2017: 165.14 million shares | Q1 2018: 208.90 million shares | Q3 2018: 233.72 million shares | Q4 2018: 290.65 million shares | Q1 2019: 304.52 million shares | Q3 2019: 383.43 million shares | Q4 2019: 329.55 million shares | Q1 2020: 470.81 million shares | Q3 2020: 569.88 million shares | Q4 2020: 589.84 million shares | Q1 2021: 608.98 million shares | Q3 2021: 643.68 million shares | Q4 2021: 685.42 million shares | Q1 2022: 713.29 million shares | Q3 2022: 812.26 million shares | Q4 2022: 824.84 million shares | Q1 2023: 836.59 million shares | Q3 2023: 930.96 million shares | Q4 2023: 971.29 million shares | Q1 2024: 989.93 million shares | Q3 2024: 1.22 billion shares | Q4 2024: 1.22 billion shares | Q1 2025: 1.23 billion shares | Q2 2025: 1.25 billion shares | Q3 2025: 1.26 billion shares | Q4 2025: 1.27 billion shares.
• Over the full 15 years of available data (2011 to 2025), CytoDyn Inc.'s Common Stock Shares Outstanding has grown by 5,503.9%.
• Historical annual values: Fiscal year 2025: 1.25 billion shares | Fiscal year 2024: 1.06 billion shares | Fiscal year 2023: 918.61 million shares | Fiscal year 2022: 719.59 million shares | Fiscal year 2021: 625.68 million shares | Fiscal year 2020: 518.98 million shares | Fiscal year 2019: 329.40 million shares | Fiscal year 2018: 216.72 million shares | Fiscal year 2017: 149.47 million shares | Fiscal year 2016: 123.34 million shares | Fiscal year 2015: 63.64 million shares | Fiscal year 2014: 55.75 million shares | Fiscal year 2013: 30.91 million shares | Fiscal year 2012: 28.64 million shares | Fiscal year 2011: 22.29 million shares.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026